once-weekly semaglutide in persons with obesity and knee osteoarthritis Wegovy Reduced Pain From Once-Weekly Semaglutide in Adults with

Patients with naturally high baseline leptin and peptide YY levels may respond at lower doses, while those with resistant hunger signals may need to advance more quickly

Both tirzepatide and life without a gallbladder can cause diarrhea , bloating , and nausea

Such ratio significantly increased from baseline after 26 weeks of treatment with liraglutide 1.8 mg/day, indicating a reduction in liver steatosis, whereas it was unchanged in patients treated with lower doses of liraglutide, glimepiride or placebo

Associations between polygenic risk scores for cardiometabolic phenotypes and adolescent depression and body dissatisfaction

Accelerated approval guidance is only available if program criteria are met and surrogate endpoints are available with sufficient evidence to be used as a predictor of clinical benefit